Balloon-Expandable vs Self-Expanding Valves for Transcatheter Treatment of Sievers Type 1 Bicuspid Aortic Stenosis.

Autor:	Buono A; Valve Center, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy., Zito A; Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, Rome, Italy., Kim WK; Kerckhoff Heart Center, Bad Nauheim, Germany; Medical Clinic I, Department of Cardiology and Angiology, Justus-Liebig University of Giessen/Marburg, Giessen, Germany., Fabris T; Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua Medical School, Padua, Italy., De Biase C; Groupe Cardiovasculaire Interventionnel, Clinique Pasteur, Toulouse, France., Bellamoli M; Valve Center, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy., Montarello N; The Heart Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Costa G; U.O.C. Cardiologia, Centro Alte Specialità e Trapianti, P.O.G. Rodolico, A.O.U. Policlinico-V. Emanuele, Università di Catania, Catania, Italy., Alfadhel M; Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom., Koren O; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Fezzi S; Department of Cardiology, University Hospitals Galway, Galway, Ireland., Bellini B; Interventional Cardiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Massussi M; Civil Hospital and University of Brescia, Brescia, Italy., Scotti A; Montefiore Medical Center, New York, New York, USA., Bai L; Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China., Costa G; Cardiac Catheterization Laboratory, University of Pisa and Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Mazzapicchi A; Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Giacomin E; Cardiology Unit, Cardio-Neuro-Vascular Department, Ca' Foncello Hospital Azienda N 2 Marca Trevigiana, Treviso, Italy., Gorla R; Department of Cardiology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy., Hug K; Department of Cardiovascular Diseases, German Heart Center Munich, Technical University Munich, Munich, Germany., Briguori C; Interventional Cardiology Unit, Mediterranea Cardiocentro, Naples, Italy., Bettari L; Valve Center, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy., Messina A; Valve Center, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy., Boiago M; Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua Medical School, Padua, Italy., Villa E; Valve Center, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy., Renker M; Kerckhoff Heart Center, Bad Nauheim, Germany; Medical Clinic I, Department of Cardiology and Angiology, Justus-Liebig University of Giessen/Marburg, Giessen, Germany., Garcia Gomez M; CIBERCV, Division of Cardiology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Fraccaro C; Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua Medical School, Padua, Italy., De Rosa ML; Valve Center, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy., Patel V; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Trani C; Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, Rome, Italy., De Carlo M; Cardiac Catheterization Laboratory, University of Pisa and Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Laterra G; Università degli Studi di Enna 'Kore,' Enna, Italy., Latini A; Cardio Center, IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy., Pellegrini D; Edith Wolfson Medical Center, Cardiology Department, Holon, Israel and Tel-Aviv University, Tel-Aviv, Israel., Ielasi A; Edith Wolfson Medical Center, Cardiology Department, Holon, Israel and Tel-Aviv University, Tel-Aviv, Israel., Orbach A; Division of Cardiology, IRCCS Hospital Galeazzi-Sant'Ambrogio, Milan, Italy., Landes U; Division of Cardiology, IRCCS Hospital Galeazzi-Sant'Ambrogio, Milan, Italy., Rheude T; Department of Cardiovascular Diseases, German Heart Center Munich, Technical University Munich, Munich, Germany., Testa L; Department of Cardiology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy., Amat Santos I; CIBERCV, Division of Cardiology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Mangieri A; Cardio Center, IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy., Saia F; Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Favero L; Cardiology Unit, Cardio-Neuro-Vascular Department, Ca' Foncello Hospital Azienda N 2 Marca Trevigiana, Treviso, Italy., Chen M; Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China., Adamo M; Civil Hospital and University of Brescia, Brescia, Italy., Latib A; Montefiore Medical Center, New York, New York, USA., Sonia Petronio A; Cardiac Catheterization Laboratory, University of Pisa and Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Montorfano M; School of Medicine, Vita-Salute San Raffaele University, Milan, Italy; Interventional Cardiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Makkar RR; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Mylotte D; Department of Cardiology, University Hospitals Galway, Galway, Ireland., Blackman DJ; Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom., Burzotta F; Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, Rome, Italy., Barbanti M; Università degli Studi di Enna 'Kore,' Enna, Italy., De Backer O; The Heart Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Tchètchè D; Groupe Cardiovasculaire Interventionnel, Clinique Pasteur, Toulouse, France., Maffeo D; Valve Center, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy., Tarantini G; Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua Medical School, Padua, Italy. Electronic address: giuseppe.tarantini.1@gmail.com.
Jazyk:	angličtina
Zdroj:	JACC. Cardiovascular interventions [JACC Cardiovasc Interv] 2024 Sep 03. Date of Electronic Publication: 2024 Sep 03.
DOI:	10.1016/j.jcin.2024.07.031
Abstrakt:	Background: Balloon-expandable valves (BEVs) and self-expanding valves (SEVs) have different features that may impact the outcomes of patients with Sievers type 1 bicuspid aortic valve (BAV) stenosis undergoing transcatheter aortic valve replacement. Objectives: This study sought to compare procedural and clinical outcomes of BEVs and SEVs in Sievers type 1 BAV stenosis. Methods: AD-HOC (Characteristics, Sizing, and Outcomes of Stenotic Raphe-Type Bicuspid Aortic Valves Treated With Transcatheter Device Implantation) is an observational registry enrolling patients with Sievers type 1 BAV stenosis undergoing transcatheter aortic valve replacement with current-generation BEVs and SEVs at 24 international centers. A 1:1 propensity score matching analysis was performed to adjust for baseline imbalances. The primary endpoint was midterm major adverse events, defined as a composite of all-cause death, neurologic events, or hospitalization for heart failure. Results: Among 955 eligible patients, propensity score matching resulted in 301 pairs. At a median follow-up of 1.3 years, BEVs and SEVs had a similar risk of major adverse events (BEV vs SEV: HR: 0.75; 95% CI: 0.49-1.16; P = 0.200). Technical success was similar (OR: 1.38; 95% CI: 0.63-3.04; P = 0.421). At 30 days, BEVs were associated with a lower risk of new permanent pacemaker implantation (OR: 0.42; 95% CI: 0.24-0.72; P = 0.002) and moderate or greater paravalvular regurgitation (OR: 0.16; 95% CI: 0.05-0.48; P = 0.001) but a higher risk of severe patient-prosthesis mismatch (OR: 3.03; 95% CI 1.02-8.95; P = 0.045). Conclusions: Current-generation BEVs and SEVs proved similar technical success and midterm clinical efficacy in Sievers type 1 BAV stenosis. Compared to SEVs, BEVs were associated with less permanent pacemaker implantation and moderate or greater paravalvular regurgitation but with more severe patient-prosthesis mismatch. Competing Interests: Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose. (Copyright © 2024 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu